X
Gout & Other Crystal Arthropathies: Expert
Gout & Other Crystal Arthropathies: Expert
Gout & Other Crystal Arthropathies: Expert

Gout & Other Crystal Arthropathies: Expert Consult: Online and Print

Product ID : 37632659
4 out of 5 stars


Galleon Product ID 37632659
UPC / ISBN 001437728642
Shipping Weight 2.3 lbs
I think this is wrong?
Model
Manufacturer Saunders
Shipping Dimension 10.98 x 8.82 x 0.79 inches
I think this is wrong?
-
11,547

*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
  • Electrical items MAY be 110 volts.
  • 7 Day Return Policy
  • All products are genuine and original
  • Cash On Delivery/Cash Upon Pickup Available

Pay with

About Gout & Other Crystal Arthropathies: Expert

Gout and Other Crystal Arthropathies, by Dr. Robert Terkeltaub, presents the state-of-the-art, clinically-focused coverage you need to manage these increasingly prevalent diseases. Diagnose the full range of crystal arthropathies―including pseudogout, intercritical gout, hyperuricemia, and gouty arthritis―and treat your patients effectively with discussions of recently-approved drugs like Uloric and those currently under review, such as Kristexxa and Colcryst. With coverage of the latest therapies, preventions, and imaging studies, along with access to the fully searchable text online at www.expertconsult.com, this comprehensive resource is ideal for any physician who diagnoses, treats, and manages gout and crystal-induced arthropathies. Access the fully searchable contents online at www.expertconsult.com. Stay current on recent developments such as uricosuric therapy and inhibitor therapy; gout flare prophylaxis and colchicines; ultrasound in the diagnosis of crystal deposition diseases; imaging of gout, CPPD, and hydroxyapatitie deposition diseases; and uricase therapy of gout. Manage the full range of crystal arthropathies with 25 clinically-focused chapters on pseudogout, intercritical gout, hyperuricemia, gouty arthritis, and more. Treat your patients effectively using the latest information on drug treatments, from the recently-approved Uloric to Kristexx and Colcryst, which are still under review.